Akèy › Kolestewòl › Texas
Etid klinik pou Kolestewòl nan Texas
6 etid pou Kolestewòl ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- PharmaTex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Inc., Amarillo
- Austin Heart, Austin
- ak 8 plis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- ak 3 plis
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Sep 10, 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research Dallas, Dallas
- Valley Institute of Research, Rockwood Medical Clinic, Fort Worth
- Be Well Clinical Studies - Round Rock, Round Rock
- ak 3 plis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT07477704Multicomponent Intervention Study- Blood Donors With High Cholesterol
- UT Southwestern Medical Center, Dallas
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Mar 17, 2026 · NCT05693701Alirocumab in Patients on a Stable Dialysis Regimen
- Baylor Soltero CV Research, Dallas
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Feb 12, 2020 · NCT03480568Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.